Concept review of dry powder inhalers

correct interpretation of published data

David Price, Henry Chrystyn

Research output: Contribution to journalLetter

2 Citations (Scopus)
4 Downloads (Pure)

Abstract

Dry powder inhalers (DPIs) are widely used in the clinical practice for delivering therapeutics to patients with lung diseases, such as chronic obstructive pulmonary disease. An overview of current DPIs available on the market from high resistance to low resistance has been reported in a recent review article. We assessed this concept review article and believe this letter provides important additional information regarding the correct interpretation of the data on low resistance DPIs.

Original languageEnglish
Article number36
JournalMultidisciplinary respiratory medicine
Volume10
DOIs
Publication statusPublished - 2 Dec 2015

Fingerprint

Dry Powder Inhalers
Chronic Obstructive Pulmonary Disease
Lung Diseases
Therapeutics

Keywords

  • Chronic Obstructive Pulmonary Disease
  • hronic Obstructive Pulmonary Disease Patient
  • Inspiratory Effort
  • Indacaterol
  • Medium Resistance

Cite this

Concept review of dry powder inhalers : correct interpretation of published data. / Price, David; Chrystyn, Henry.

In: Multidisciplinary respiratory medicine, Vol. 10, 36, 02.12.2015.

Research output: Contribution to journalLetter

@article{7c0048e604604a1993f0b2d7b629da87,
title = "Concept review of dry powder inhalers: correct interpretation of published data",
abstract = "Dry powder inhalers (DPIs) are widely used in the clinical practice for delivering therapeutics to patients with lung diseases, such as chronic obstructive pulmonary disease. An overview of current DPIs available on the market from high resistance to low resistance has been reported in a recent review article. We assessed this concept review article and believe this letter provides important additional information regarding the correct interpretation of the data on low resistance DPIs.",
keywords = "Chronic Obstructive Pulmonary Disease, hronic Obstructive Pulmonary Disease Patient, Inspiratory Effort, Indacaterol, Medium Resistance",
author = "David Price and Henry Chrystyn",
year = "2015",
month = "12",
day = "2",
doi = "10.1186/s40248-015-0033-0",
language = "English",
volume = "10",
journal = "Multidisciplinary respiratory medicine",
issn = "1828-695X",
publisher = "Novamedia s.r.l.",

}

TY - JOUR

T1 - Concept review of dry powder inhalers

T2 - correct interpretation of published data

AU - Price, David

AU - Chrystyn, Henry

PY - 2015/12/2

Y1 - 2015/12/2

N2 - Dry powder inhalers (DPIs) are widely used in the clinical practice for delivering therapeutics to patients with lung diseases, such as chronic obstructive pulmonary disease. An overview of current DPIs available on the market from high resistance to low resistance has been reported in a recent review article. We assessed this concept review article and believe this letter provides important additional information regarding the correct interpretation of the data on low resistance DPIs.

AB - Dry powder inhalers (DPIs) are widely used in the clinical practice for delivering therapeutics to patients with lung diseases, such as chronic obstructive pulmonary disease. An overview of current DPIs available on the market from high resistance to low resistance has been reported in a recent review article. We assessed this concept review article and believe this letter provides important additional information regarding the correct interpretation of the data on low resistance DPIs.

KW - Chronic Obstructive Pulmonary Disease

KW - hronic Obstructive Pulmonary Disease Patient

KW - Inspiratory Effort

KW - Indacaterol

KW - Medium Resistance

U2 - 10.1186/s40248-015-0033-0

DO - 10.1186/s40248-015-0033-0

M3 - Letter

VL - 10

JO - Multidisciplinary respiratory medicine

JF - Multidisciplinary respiratory medicine

SN - 1828-695X

M1 - 36

ER -